The use of Bovhyaluronidaze azoximer preparation in the treatment of suppurative wounds in companion animals
| Autor: | Anatoly Stekolnikov, Tatiana Kuznetsova, B. N. Semenov, Anna Nazarova |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Environmental Engineering
CATS lcsh:QP1-981 business.industry Treatment duration lcsh:QR1-502 Industrial and Manufacturing Engineering lcsh:Microbiology lcsh:Physiology 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Anesthesia Edema lcsh:Zoology medicine Wound cleansing lcsh:QL1-991 medicine.symptom 030223 otorhinolaryngology business |
| Zdroj: | BIO Web of Conferences, Vol 27, p 00026 (2020) |
| ISSN: | 2117-4458 |
| Popis: | Increasing the number of dogs and cats kept in urban households makes relevant research of new effective methods of treatment of companion animals. We conducted studies of the effect of Bovhyaluronidaze azoximer on the treatment duration of suppurative wounds. The study was carried out on 42 animals (24 cats and 18 dogs) with septic processes in two groups. The animals of the both groups were given conventional therapy; in animals of the experimental group the Bovhyaluronidaze azoximer preparation was additionally included as a part of a complex therapy. The effect of the use Bovhyaluronidaze azoximer preparation was evaluated by three indicators: the wound cleansing from purulonecrotic masses duration, the duration of existence of edema, the number of managements of wound. The median wound cleansing time in the experimental group improve on 2.29 days. The median duration of existence of edema in the experimental group was in less time on 1.57 days in comparison with the control group. The median number of required managements of wound is reduced by 5.00 manipulations in the experimental group in comparison with the control group. The results of our study show that Bovhyaluronidaze azoximer can be recommended for use in the therapy of suppurative wounds. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|